April 17, 2014

Statin Drugs Shown to Increase Risk of Diabetes Significantly, Yet the Media Scramble to Protect the Drugs’ Reputation

lipitor Statin Drugs Shown to Increase Risk of Diabetes Significantly, Yet the Media Scramble to Protect the Drugs’ Reputation

by Alliance for Natural Health

Statins are taken by one in four Americans over the age of 45, even though diet can fix high cholesterol quicker and more safely. Here’s new evidence of the drugs’ dangers.

A University of Massachusetts Medical School study has found that statins significantly increase risk of type 2 diabetes among postmenopausal women—an increased rate of 48% compared to those not on cholesterol-lowering drugs. The data comes from the massive Women’s Health Initiative, which surveyed 161,808 women.

Interestingly, this is not the first study to reveal such a link. A 2011 study found that the risk of adult-onset diabetes is much higher in patients who take high doses of statin drugs. And a 2010 meta-analysis found that statin therapy of any dosage was associated with 9% greater risk of diabetes.

But in the face of this research, the media is bending over backwards to say that the risk of statins do not outweigh the “benefits”! The headline of the Associated Press article (which was picked up by countless media outlets) says that statins are linked to “small diabetes risk,” calling them “cholesterol-lowering wonder drugs.”

The article continues, “Specialists say people who most need statins because of a high risk for a heart attack should stick with the drugs,” and quotes a doctor not involved with the research as saying, “What I fear here is that people who need and will benefit from statins will be scared off of using the drugs because of reports like this.” The AP also notes that more and more doctors are urging otherwise healthy people to use the pills as a way to prevent heart disease.

Conspicuously absent is any reference to recent findings from mainstream medical authorities that statins show no benefit whatsoever in reducing cardiovascular disease risk among patients who are currently at low risk of heart attack.

WebMD’s analysis of the study quickly states, “Experts say the evidence as a whole suggests that the risks are slight and that for most women who take statins, the benefits for preventing heart attack and stroke outweigh those risks.”

Let’s look at some of those “benefits.” As we reported recently, statin drugs:

  • Weaken the immune system and make it difficult to fight off bacterial infections, and increase the production of cytokines, which trigger and sustain inflammation.
  • Make some patients unable to concentrate or remember words, and is linked to muscle and neurological problems, including Lou Gehrig’s Disease.
  • Have documented side effects which include nerve damage, muscle damage, liver enzyme derangement, and in some cases even kidney failure, not to mention, tendon problems, anemia, acidosis, cataracts, and sexual dysfunction.

This is all in addition to the blood glucose elevation and increased risk of diabetes.

Even more outrageously, some years ago the British Medical Journal advocated widespread use of a polypill that combines six different drugs—a statin, three low-dose antihypertensives (thiazide, an ACE inhibitor, and a beta-blocker), folic acid, and aspirin. In an editorial last year, MedPage Today, a service for physicians that gives medical news from a clinical perspective, suggested putting this combination directly into the water supply—though, it said, “we could probably drop the folic acid.”

(Dropping folic acid is not a bad choice, actually: it’s a synthetic, oxidized form of the B vitamin which can build up in the bloodstream and may become carcinogenic if you have too much. If you want plenty of natural folate, eat lots of dark green vegetables or get the reduced form, 5-methyl tetrahydrofolate [5-MHTF] in high-quality supplements!)

Now let’s contrast mainstream media’s support of statins and other dangerous drugs with their negative coverage of natural approaches to good health, including supplements. Look how many recent articles have made outrageous and demonstrably false statements like antioxidants not necessarily being good for one’s health, or vitamin use leading to an earlier death. The ultimate irony is that any time safety issues with very high-dose supplements have cropped up, as shown with beta-carotene and later with vitamin E, they’ve always been linked with the isolated, pharmaceutical forms of these vitamins, not the natural forms.

Remember the media coverage around the vitamin D study last November? The media said that people who take too much vitamin D were 2½ times more likely to develop atrial fibrillation—which, as we reported, the actual study absolutely did not say—thus scaring people away from an essential supplement. This is especially tragic since at least one-third of all Americans are actually deficient in vitamin D.

Do we really need any further evidence that conventional medicine, multinational pharmaceutical manufacturers, and the advertising industry are working hand-in-hand to further their own interests—and are using a compliant media (who are utterly dependent on advertisers) to carry out their agenda?

Read the Full Article Here: http://www.anh-usa.org/media-scramble-to-protect-statin-reputation/

Fat and Cholesterol are Good for You!
What REALLY Causes Heart Disease
by Uffe Ravnskov, MD, PhD

fat and cholesterol are good for you Statin Drugs Shown to Increase Risk of Diabetes Significantly, Yet the Media Scramble to Protect the Drugs’ Reputation

Free Shipping Available!

0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!